| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8432039 | Blood Reviews | 2017 | 6 Pages |
Abstract
This review summarizes the preclinical and clinical data on the efficacy of exogenous transferrin administration to modulate certain forms of anemia and to prevent the toxic effects of free iron. Thereby, we show that transferrin has promising therapeutic potential in a wide variety of conditions.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
M. Boshuizen, K. van der Ploeg, L. von Bonsdorff, B.J. Biemond, S.S. Zeerleder, R. van Bruggen, N.P. Juffermans,